in the third quarter of fiscal 2017 , we completed the application development stage of our enterprise resource planning ( `` erp `` ) system , and we began depreciating our investment in such system . we incurred increased depreciation and other operating expenses of approximately $ 25.0 million in the fiscal year ended april 29 , 2017 as compared to the fiscal year ended april 30 , 2016 , related to this implementation . intangible asset impairment . in fiscal 2006 , we extended our exclusive north american distribution relationship with sirona dental systems for sirona 's cerec 3d dental restorative system . at that time , we paid a $ 100.0 million distribution fee to extend the existing exclusive relationship for at least a 10-year period beginning in 2007. this distribution fee has been accounted for as an intangible asset that has been amortized since 2007. based on our november 2016 decision not to extend sales exclusivity for the full sirona portfolio of products , we recorded a pre-tax non-cash impairment charge of $ 36.3 million , or $ 23.0 million after taxes or $ 0.24 per diluted share in our dental segment in the third quarter of fiscal 2017 , related to the distribution fee associated with the cerec product component of this arrangement . animal health international acquisition . in june 2015 , we completed the acquisition of animal health international , inc. , a leading production animal health distribution company in the u.s. prior to our acquisition , animal health international , inc. generated sales and earnings before interest , income taxes , depreciation and amortization 31 of $ 1.5 billion and $ 68 million , respectively , during the 12 months ended march 2015. our acquisition more than doubled the revenue of our legacy animal health business , which was previously focused on the companion animal market . our animal health business now offers an expanded range of products and services to a broader base of customers in north america and the u.k. during fiscal 2016 , we incurred $ 10.4 million , or $ 0.11 per diluted share , on an after-tax basis , of transaction costs related to the acquisition of animal health international , inc. patterson medical sale . in august 2015 , we sold patterson medical for $ 716.9 million . see note 4 to the consolidated financial statements for additional information . story_separator_special_tag discontinued operations net loss from discontinued operations was $ 2.9 million in fiscal 2017 , compared to net income from discontinued operations of $ 1.5 million in fiscal 2016 . the net loss incurred during fiscal 2017 was due to a change in estimate of the tax impact of the sale of patterson medical . 33 fiscal 2016 compared to fiscal 2015 continuing operations net sales . consolidated net sales in fiscal 2016 were $ 5,386.7 million , an increase of 37.7 % from $ 3,910.9 million in fiscal 2015. the growth in sales includes a 35.7 % contribution from acquisitions and a 1.8 % unfavorable impact of changes in foreign currency exchange rates . dental segment sales rose 2.5 % to $ 2,476.2 million in fiscal 2016 from $ 2,415.0 million in fiscal 2015. the growth included a 1.3 % unfavorable impact from changes in foreign currency exchange rates . consumable sales increased 4.5 % . dental equipment and software sales decreased 1.4 % , driven by a 1.3 % unfavorable impact from changes in foreign currency exchange rates . other dental sales , consisting primarily of technical service parts and labor , software support services and artificial teeth , increased 4.7 % in fiscal 2016. animal health segment sales grew 96.5 % to $ 2,862.2 million in fiscal 2016 from $ 1,456.6 million in fiscal 2015. our acquisition of animal health international , inc. in fiscal 2016 drove most of the increase in sales , contributing $ 1,396.1 million in sales in fiscal 2016. consumables increased 101.4 % , driven almost entirely by sales from animal health international , inc. equipment and software sales increased 7.2 % , and other sales increased 17.3 % , with both increases driven by organic growth and partially offset by unfavorable impacts from changes in foreign currency exchange rates . gross profit . consolidated gross profit margin for fiscal 2016 decreased 250 basis points from the prior year to 24.6 % . the decrease in gross profit margin was predominantly the result of the inclusion of sales and cost of sales from animal health international , inc. in our results , as that business traditionally has lower gross margins than our historical businesses . operating expenses . consolidated operating expenses for fiscal 2016 were $ 975.0 million , a 29.0 % increase from the prior year of $ 756.0 million . operating expenses mainly increased due to the acquisition of animal health international , inc. and transaction-related costs . the consolidated operating expense ratio of 18.1 % decreased 120 basis points from the prior year , primarily due to the acquisition of animal health international , inc. , which has a lower operating expense ratio than our other business . operating income from continuing operations . operating income from continuing operations was $ 347.7 million , or 6.5 % of net sales , in fiscal 2016 , compared to $ 304.6 million , or 7.8 % of sales , in fiscal 2015. the decrease in operating income as a percent of net sales was mainly due to the inclusion of results of animal health international , inc. and transaction-related costs . dental segment operating income was $ 312.2 million for fiscal 2016 , an increase of $ 11.8 million from the prior year period . the increase was driven primarily by higher sales volumes . animal health segment operating income was $ 94.3 million for fiscal 2016 , an increase of $ 37.6 million from the prior year period . story_separator_special_tag receivables are written off when we determine the amounts to be uncollectible , typically upon customer bankruptcy or non-response to continuous collection efforts . the portions of receivable amounts that are not expected to be collected during the next twelve months are classified as long-term . patterson has a relatively large , dispersed customer base and no single customer accounts for more than 1 % of consolidated net sales . in addition , the equipment sold to customers under finance contracts generally serves as collateral for the contract and the customer provides a personal guarantee as well . patterson advantage loyalty program – patterson dental provides a point-based awards program to qualifying customers involving the issuance of “ patterson advantage dollars ” which can be used toward equipment and technology purchases . the program was initiated in january 2009 and runs on a calendar year schedule . patterson advantage dollars earned during a program year expire one year after the end of the program year . the cost and corresponding liability associated with the program is recognized as contra-revenue in accordance with asc topic 605-50 , “ revenue recognition-customer payments and incentives . ” as of april 29 , 2017 , we believe we have sufficient experience with the program to reasonably estimate the amount of patterson advantage dollars that will not be redeemed and thus have recorded a liability for 87 % of the maximum potential amount that could be redeemed . we use the redemption recognition method , and we recognize the estimated value of unused patterson advantage dollars as redemptions occur . breakage recognized was immaterial to all periods presented . inventory and reserves – inventory consists primarily of merchandise held for sale and is stated at the lower of cost or market . cost is determined using the last-in , first-out ( `` lifo `` ) method for all inventories , except for foreign inventories and manufactured inventories , which are valued using the first-in , first-out ( `` fifo `` ) method . we continually assess the valuation of inventories and reduce the carrying value of those inventories that are obsolete or in excess of forecasted usage to estimated realizable value . estimates are made of the net realizable value of such inventories based on analyses and assumptions including , but not limited to , historical usage , future demand and market requirements . goodwill and other indefinite-lived intangible assets – goodwill represents the excess of cost over the fair value of identifiable net assets of businesses acquired . we have two reporting units as of april 29 , 2017 ; dental and animal health . our corporate reportable segment 's assets and liabilities , and net sales and expenses , are allocated to the two reporting units . other indefinite-lived intangible assets include copyrights , trade names and trademarks . we evaluate goodwill at least annually . if we determine that the fair value of the reporting unit may be less than its carrying amount , we evaluate goodwill using a two-step impairment test . otherwise , we conclude that no impairment is indicated and we do not perform the two-step impairment test . in fiscal 2017 , we determined it was appropriate to perform a two-step impairment test . the first step of the goodwill impairment test compares the book value of a reporting unit , including goodwill , with its fair value , as determined by its discounted cash flows . if the book value of a reporting unit exceeds its fair value , 38 the second step of the impairment test is performed to determine the amount of goodwill impairment loss to be recorded . the determination of fair value involves uncertainties because it requires management to make assumptions and to apply judgment to estimate industry and economic factors and the profitability of future business strategies . patterson conducts impairment testing based on current business strategy in light of present industry and economic conditions , as well as future expectations . additionally , in assessing goodwill for impairment , the reasonableness of the implied control premium is considered based on market capitalizations and recent market transactions . other indefinite-lived intangible assets are assessed for impairment by comparing the carrying value of an asset with its fair value . if the carrying value exceeds fair value , an impairment loss is recognized in an amount equal to the excess . the determination of fair value involves assumptions , including projected revenues and gross profit levels , as well as consideration of any factors that may indicate potential impairment . in the fourth quarter of fiscal 2017 , management completed its annual goodwill and other indefinite-lived intangible asset impairment tests and determined there was no impairment , and that our dental reporting unit was not at risk of failing step 1. the animal health reporting unit has a higher level of sensitivity to impairment as management currently assesses the various estimates and assumptions used to conduct these tests . adverse changes to one or more of these estimates or assumptions could cause us to recognize a material impairment charge on this reporting unit . at april 29 , 2017 , the estimated fair value of the animal health reporting unit exceeded its book value by approximately 11 % . long-lived assets – long-lived assets , including definite-lived intangible assets , are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets . our definite-lived intangible assets primarily consist of customer lists . when impairment exists , the related assets are written down to fair value using level 3 inputs , as discussed further in note 9 to the consolidated financial statements . in fiscal 2017 , we recorded a non-cash impairment charge of $ 36.3 million related to a distribution agreement intangible asset . refer to note 3 to the consolidated

cash repatriation . in fiscal 2016 , we approved a one-time repatriation of approximately $ 200.0 million of foreign earnings . this one-time repatriation reduced the overall cost of funding the acquisition of animal health international , inc. in addition , certain foreign cash at patterson medical was required to be repatriated as part of the sale transaction . a continuing operations tax impact of $ 12.3 million from the repatriation was recorded during fiscal 2016. during fiscal 2017 , we recorded a $ 2.4 million tax benefit related to a change in estimate of the tax impact of the cash repatriation . see note 11 to the consolidated financial statements for additional information . results of operations the following table summarizes our results from continuing operations as a percent of sales from continuing operations : replace_table_token_7_th fiscal 2017 compared to fiscal 2016 continuing operations net sales . consolidated net sales in fiscal 2017 were $ 5,593.1 million , an increase of 3.8 % from $ 5,386.7 million in fiscal 2016 . the inclusion of animal health international , inc. results for approximately six additional weeks in fiscal 2017 had a 3.6 % favorable impact on sales , foreign exchange rate changes had an estimated 1.7 % unfavorable impact on fiscal 2017 sales , and one less week of results in fiscal 2017 had a 1.0 % unfavorable impact on sales , resulting in internal growth of 2.9 % . dental segment sales decreased 3.5 % to $ 2,390.2 million in fiscal 2017 from $ 2,476.2 million in fiscal 2016 . one less week of results in the current period had an estimated 1.1 % unfavorable impact on sales . adjusting for this difference in number of weeks , sales decreased 2.4 % . sales of consumables decreased 4.1 % , primarily due to having one less week of results in the current period and to a sales force realignment in the first quarter of fiscal 2017. dental equipment and software sales decreased 3.2 % , primarily due to a decrease in sales of digital products , partially offset by increased sales of core equipment .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```cash repatriation . in fiscal 2016 , we approved a one-time repatriation of approximately $ 200.0 million of foreign earnings . this one-time repatriation reduced the overall cost of funding the acquisition of animal health international , inc. in addition , certain foreign cash at patterson medical was required to be repatriated as part of the sale transaction . a continuing operations tax impact of $ 12.3 million from the repatriation was recorded during fiscal 2016. during fiscal 2017 , we recorded a $ 2.4 million tax benefit related to a change in estimate of the tax impact of the cash repatriation . see note 11 to the consolidated financial statements for additional information . results of operations the following table summarizes our results from continuing operations as a percent of sales from continuing operations : replace_table_token_7_th fiscal 2017 compared to fiscal 2016 continuing operations net sales . consolidated net sales in fiscal 2017 were $ 5,593.1 million , an increase of 3.8 % from $ 5,386.7 million in fiscal 2016 . the inclusion of animal health international , inc. results for approximately six additional weeks in fiscal 2017 had a 3.6 % favorable impact on sales , foreign exchange rate changes had an estimated 1.7 % unfavorable impact on fiscal 2017 sales , and one less week of results in fiscal 2017 had a 1.0 % unfavorable impact on sales , resulting in internal growth of 2.9 % . dental segment sales decreased 3.5 % to $ 2,390.2 million in fiscal 2017 from $ 2,476.2 million in fiscal 2016 . one less week of results in the current period had an estimated 1.1 % unfavorable impact on sales . adjusting for this difference in number of weeks , sales decreased 2.4 % . sales of consumables decreased 4.1 % , primarily due to having one less week of results in the current period and to a sales force realignment in the first quarter of fiscal 2017. dental equipment and software sales decreased 3.2 % , primarily due to a decrease in sales of digital products , partially offset by increased sales of core equipment .
```    
 Suspicious Activity Report : in the third quarter of fiscal 2017 , we completed the application development stage of our enterprise resource planning ( `` erp `` ) system , and we began depreciating our investment in such system . we incurred increased depreciation and other operating expenses of approximately $ 25.0 million in the fiscal year ended april 29 , 2017 as compared to the fiscal year ended april 30 , 2016 , related to this implementation . intangible asset impairment . in fiscal 2006 , we extended our exclusive north american distribution relationship with sirona dental systems for sirona 's cerec 3d dental restorative system . at that time , we paid a $ 100.0 million distribution fee to extend the existing exclusive relationship for at least a 10-year period beginning in 2007. this distribution fee has been accounted for as an intangible asset that has been amortized since 2007. based on our november 2016 decision not to extend sales exclusivity for the full sirona portfolio of products , we recorded a pre-tax non-cash impairment charge of $ 36.3 million , or $ 23.0 million after taxes or $ 0.24 per diluted share in our dental segment in the third quarter of fiscal 2017 , related to the distribution fee associated with the cerec product component of this arrangement . animal health international acquisition . in june 2015 , we completed the acquisition of animal health international , inc. , a leading production animal health distribution company in the u.s. prior to our acquisition , animal health international , inc. generated sales and earnings before interest , income taxes , depreciation and amortization 31 of $ 1.5 billion and $ 68 million , respectively , during the 12 months ended march 2015. our acquisition more than doubled the revenue of our legacy animal health business , which was previously focused on the companion animal market . our animal health business now offers an expanded range of products and services to a broader base of customers in north america and the u.k. during fiscal 2016 , we incurred $ 10.4 million , or $ 0.11 per diluted share , on an after-tax basis , of transaction costs related to the acquisition of animal health international , inc. patterson medical sale . in august 2015 , we sold patterson medical for $ 716.9 million . see note 4 to the consolidated financial statements for additional information . story_separator_special_tag discontinued operations net loss from discontinued operations was $ 2.9 million in fiscal 2017 , compared to net income from discontinued operations of $ 1.5 million in fiscal 2016 . the net loss incurred during fiscal 2017 was due to a change in estimate of the tax impact of the sale of patterson medical . 33 fiscal 2016 compared to fiscal 2015 continuing operations net sales . consolidated net sales in fiscal 2016 were $ 5,386.7 million , an increase of 37.7 % from $ 3,910.9 million in fiscal 2015. the growth in sales includes a 35.7 % contribution from acquisitions and a 1.8 % unfavorable impact of changes in foreign currency exchange rates . dental segment sales rose 2.5 % to $ 2,476.2 million in fiscal 2016 from $ 2,415.0 million in fiscal 2015. the growth included a 1.3 % unfavorable impact from changes in foreign currency exchange rates . consumable sales increased 4.5 % . dental equipment and software sales decreased 1.4 % , driven by a 1.3 % unfavorable impact from changes in foreign currency exchange rates . other dental sales , consisting primarily of technical service parts and labor , software support services and artificial teeth , increased 4.7 % in fiscal 2016. animal health segment sales grew 96.5 % to $ 2,862.2 million in fiscal 2016 from $ 1,456.6 million in fiscal 2015. our acquisition of animal health international , inc. in fiscal 2016 drove most of the increase in sales , contributing $ 1,396.1 million in sales in fiscal 2016. consumables increased 101.4 % , driven almost entirely by sales from animal health international , inc. equipment and software sales increased 7.2 % , and other sales increased 17.3 % , with both increases driven by organic growth and partially offset by unfavorable impacts from changes in foreign currency exchange rates . gross profit . consolidated gross profit margin for fiscal 2016 decreased 250 basis points from the prior year to 24.6 % . the decrease in gross profit margin was predominantly the result of the inclusion of sales and cost of sales from animal health international , inc. in our results , as that business traditionally has lower gross margins than our historical businesses . operating expenses . consolidated operating expenses for fiscal 2016 were $ 975.0 million , a 29.0 % increase from the prior year of $ 756.0 million . operating expenses mainly increased due to the acquisition of animal health international , inc. and transaction-related costs . the consolidated operating expense ratio of 18.1 % decreased 120 basis points from the prior year , primarily due to the acquisition of animal health international , inc. , which has a lower operating expense ratio than our other business . operating income from continuing operations . operating income from continuing operations was $ 347.7 million , or 6.5 % of net sales , in fiscal 2016 , compared to $ 304.6 million , or 7.8 % of sales , in fiscal 2015. the decrease in operating income as a percent of net sales was mainly due to the inclusion of results of animal health international , inc. and transaction-related costs . dental segment operating income was $ 312.2 million for fiscal 2016 , an increase of $ 11.8 million from the prior year period . the increase was driven primarily by higher sales volumes . animal health segment operating income was $ 94.3 million for fiscal 2016 , an increase of $ 37.6 million from the prior year period . story_separator_special_tag receivables are written off when we determine the amounts to be uncollectible , typically upon customer bankruptcy or non-response to continuous collection efforts . the portions of receivable amounts that are not expected to be collected during the next twelve months are classified as long-term . patterson has a relatively large , dispersed customer base and no single customer accounts for more than 1 % of consolidated net sales . in addition , the equipment sold to customers under finance contracts generally serves as collateral for the contract and the customer provides a personal guarantee as well . patterson advantage loyalty program – patterson dental provides a point-based awards program to qualifying customers involving the issuance of “ patterson advantage dollars ” which can be used toward equipment and technology purchases . the program was initiated in january 2009 and runs on a calendar year schedule . patterson advantage dollars earned during a program year expire one year after the end of the program year . the cost and corresponding liability associated with the program is recognized as contra-revenue in accordance with asc topic 605-50 , “ revenue recognition-customer payments and incentives . ” as of april 29 , 2017 , we believe we have sufficient experience with the program to reasonably estimate the amount of patterson advantage dollars that will not be redeemed and thus have recorded a liability for 87 % of the maximum potential amount that could be redeemed . we use the redemption recognition method , and we recognize the estimated value of unused patterson advantage dollars as redemptions occur . breakage recognized was immaterial to all periods presented . inventory and reserves – inventory consists primarily of merchandise held for sale and is stated at the lower of cost or market . cost is determined using the last-in , first-out ( `` lifo `` ) method for all inventories , except for foreign inventories and manufactured inventories , which are valued using the first-in , first-out ( `` fifo `` ) method . we continually assess the valuation of inventories and reduce the carrying value of those inventories that are obsolete or in excess of forecasted usage to estimated realizable value . estimates are made of the net realizable value of such inventories based on analyses and assumptions including , but not limited to , historical usage , future demand and market requirements . goodwill and other indefinite-lived intangible assets – goodwill represents the excess of cost over the fair value of identifiable net assets of businesses acquired . we have two reporting units as of april 29 , 2017 ; dental and animal health . our corporate reportable segment 's assets and liabilities , and net sales and expenses , are allocated to the two reporting units . other indefinite-lived intangible assets include copyrights , trade names and trademarks . we evaluate goodwill at least annually . if we determine that the fair value of the reporting unit may be less than its carrying amount , we evaluate goodwill using a two-step impairment test . otherwise , we conclude that no impairment is indicated and we do not perform the two-step impairment test . in fiscal 2017 , we determined it was appropriate to perform a two-step impairment test . the first step of the goodwill impairment test compares the book value of a reporting unit , including goodwill , with its fair value , as determined by its discounted cash flows . if the book value of a reporting unit exceeds its fair value , 38 the second step of the impairment test is performed to determine the amount of goodwill impairment loss to be recorded . the determination of fair value involves uncertainties because it requires management to make assumptions and to apply judgment to estimate industry and economic factors and the profitability of future business strategies . patterson conducts impairment testing based on current business strategy in light of present industry and economic conditions , as well as future expectations . additionally , in assessing goodwill for impairment , the reasonableness of the implied control premium is considered based on market capitalizations and recent market transactions . other indefinite-lived intangible assets are assessed for impairment by comparing the carrying value of an asset with its fair value . if the carrying value exceeds fair value , an impairment loss is recognized in an amount equal to the excess . the determination of fair value involves assumptions , including projected revenues and gross profit levels , as well as consideration of any factors that may indicate potential impairment . in the fourth quarter of fiscal 2017 , management completed its annual goodwill and other indefinite-lived intangible asset impairment tests and determined there was no impairment , and that our dental reporting unit was not at risk of failing step 1. the animal health reporting unit has a higher level of sensitivity to impairment as management currently assesses the various estimates and assumptions used to conduct these tests . adverse changes to one or more of these estimates or assumptions could cause us to recognize a material impairment charge on this reporting unit . at april 29 , 2017 , the estimated fair value of the animal health reporting unit exceeded its book value by approximately 11 % . long-lived assets – long-lived assets , including definite-lived intangible assets , are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets . our definite-lived intangible assets primarily consist of customer lists . when impairment exists , the related assets are written down to fair value using level 3 inputs , as discussed further in note 9 to the consolidated financial statements . in fiscal 2017 , we recorded a non-cash impairment charge of $ 36.3 million related to a distribution agreement intangible asset . refer to note 3 to the consolidated

